Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 4% below Graham Number — thin margin of safety
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 17.5% — good return on equity
Pediatrix Medical Group, Inc. (MD) is a Healthcare company operating in Services-Hospitals, listed on the NYSE , with a market capitalisation of $1.6 billion . Key value metrics: P/E ratio 10.9, P/B ratio 1.90, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Pediatrix Medical Group, Inc. — Fundamental Analysis Summary
Pediatrix Medical Group, Inc. (MD) is trading 4% below its Graham Number of $20.67, offering a thin margin of safety. The stock carries a low trailing P/E ratio of 10.9x.
On financial health, MD shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and solid return on equity of 17.5% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.69.
StockPik's composite Value Score for MD is 90/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MD shows earnings growing at 267%.